Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for Coronary Small Vessels

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 236 participants.

Also called NCT06345209

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 236 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06345209
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06345209. Randomized; double masking; primary purpose treatment. Start 2024-05 (anticipated); primary completion 2024-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for Coronary Small Vessels
Intervention (Device)
Sirolimus-coated Coronary Balloon Dilatation Catheter
Intervention (Device)
Drug-coated Coronary Balloon Dilatation Catheter
Lead sponsor
BrosMed Medical Co., Ltd (class: industry)
Collaborator
Chinese Academy of Medical Sciences, Fuwai Hospital (class: other)

Record details

Record id
cardio:ct-nct06345209
Content hash
6ad168efe7ea9a98556c6a061f3632895fe7b48115b16618ef5f184f494709fe